Breckenridge Pharmaceutical Inc
General
Total Cases107
Active Cases3
Patents2
Ratings
Experience
Grade
Trend
DCT
L3
E
PTAB
L2
D
CAFC
L2
E
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 11/13/24 | NOTICE of Voluntary Dismissal by Pfizer Inc., C.P. Pharmaceuticals International C.V., PF PRISM C.V., PBG Puerto Rico LLC, PF PRISM IMB B.V. as to Breckenridge Pharmaceutical, Inc. (Dellinger, Megan) (Entered: 11/13/2024) | |
| 11/13/24 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE41,783 E. (Attachments: # [1] Notice of Dismissal) (kmd) (Entered: 11/13/2024) | |
| 11/13/24 | CASE CLOSED per [9] Notice of Dismissal. (kmd) (Entered: 11/13/2024) | |
| 10/16/24 | STANDING ORDER REGARDING BRIEFING IN ALL CASES (mws) (Entered: 10/16/2024) | |
| 10/16/24 | Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) (Entered: 10/16/2024) | |
| 10/10/24 | WAIVER OF SERVICE returned executed by Pfizer Inc., C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM IMB B.V., PF PRISM C.V.: For Breckenridge Pharmaceutical, Inc. waiver sent on 10/10/2024, answer due 12/9/2024. (Dellinger, Megan) (Entered: 10/10/2024) | |
| 10/10/24 | Summons Issued as to Breckenridge Pharmaceutical, Inc. on 10/9/2024. (mpb) (Entered: 10/10/2024) | |
| 10/10/24 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc. for C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V. filed by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V., Pfizer Inc.. (mpb) (Entered: 10/10/2024) | |
| 10/10/24 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE41,783 E. (mpb) (Entered: 10/10/2024) | |
| 10/10/24 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 8/27/2024. Date of Expiration of Patent: 12/8/2025.Thirty Month Stay Deadline: Upon Expiration of the patent (mpb) (Entered: 10/10/2024) |